WillItSurvive
BPO and customer operations firms · Egypt

IBEX

ibex.co ↗

Egypt-founded, US-listed company that runs outsourced customer support and is retooling around AI agents.

Losing its protection
Assessed 22 July 2026 · Evidence as of 22 July 2026
The structural protection is eroding.
On the recordSince 22 July 2026 · Checkable from Aug-Sep 2026 · Every call on the record Checkpoint: FY2026 full-year results confirming guidance ($638-642M revenue) and Sierra deployment scale-up
The call

IBEX is growing revenue and leaning into AI partnerships, but it resells someone else's AI technology inside a market its two largest rivals already dominate at ten times its size.

IBEX handles customer support work for companies, growing revenue 17% year-over-year by combining human agents with artificial intelligence tools through a partnership with Sierra. The problem is that larger competitors like Concentrix and Teleperformance have already built their own AI systems and serve 10 times more customers, plus newer AI companies are automating routine support questions so well that 70% or more of simple customer issues may not need humans at all. The key question is whether IBEX can use its relationships with specific industries, especially healthcare and regulated businesses, to become the middleman that manages AI tools for clients, or whether it becomes just another reseller of AI in a market where human workers are increasingly unnecessary.

Why
01
AI pressure: Sierra, Decagon and other agentic AI vendors automating tier-1 support. Agentic AI vendors sell 70%+ auto-resolution of routine tickets, the exact seat-labor work IBEX bills for today. Could AI do the core job? Yes, likely.
02
Bigger players: Concentrix (iX GenAI suite, 2,000+ bots) and Teleperformance ($10B+ revenue). Both rivals are 10x IBEX's scale and already run their own AI platforms across the same enterprise accounts IBEX chases. Could a giant copy it? Yes, easily.
03
What protects it. Enterprise integration depth and a growing HealthTech book (20.8% of revenue, up from 15.8%) with compliance ties.
What would change this call
IBEX's FY2026 Q4/full-year results (due Aug-Sep 2026) versus its raised $638-642M revenue guidance. Shows whether growth momentum against larger rivals is holding or slowing.
Whether Sierra.ai partnership becomes exclusive to IBEX or Sierra signs deals with Concentrix or Teleperformance. Reveals if IBEX's AI differentiation is defensible or easily matched by bigger rivals.
IBEX's next 10-K reconciling reported 36,000 headcount versus ~24-25,000 in independent data. Clarifies true operating scale relative to claimed growth and peer comparisons.
Key numbers
  • Q3 FY2026 revenue $164.4M, up 17% YoY (2026-03-31)
  • HealthTech grew 53.7% YoY to $34.1M (2026-03-31)
  • Reported headcount 36k vs independent estimate ~24k (2025-12-31)
Named risks
  • Core tier-1 support work directly automatable by agentic AI vendors claiming 70-73% auto-resolution. Severity: high
  • Sierra partnership is resold third-party tech, not owned IP; Sierra could go direct or partner with Concentrix. Severity: high
  • Headcount data conflict (36,000 reported vs ~24,000-25,000 independent) obscures true workforce trend. Severity: medium
  • TRG ownership stake discrepancy (13% vs 28.8%) and prior 3.56M-share sell-down create stock overhang. Severity: medium
  • Sequential EBITDA margin decline (-40bps QoQ) shows AI/offshore mix-shift gains are not yet linear. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
Concentrixlosing to450k employees, 2,000+ GenAI bots deployed by FY2024, far larger scale than IBEX
Teleperformancelosing to410k+ employees, over $10B revenue (2024: EUR10.28B), broader language footprint
Sierra (AI vendor)contestingIBEX partnered with Sierra May 5, 2026 rather than being disintermediated by it, for now
Five9contestingCCaaS software model offers enterprises an in-house alternative to IBEX's outsourced BPO model
TaskUscontestingPositions as AI-first, digital-native BPO peer competing for same enterprise clients as IBEX
Questions people ask
Is IBEX profitable in 2026?
Yes. IBEX reported Q3 FY2026 (ended March 31, 2026) adjusted net income of $13.6 million, up from about $11.8 million a year prior, with revenue of $164.4 million, up 17% YoY, and raised FY2026 guidance to $638 to 642 million revenue and $82 to 84 million adjusted EBITDA.
Could AI replace IBEX?
Partially. Vendors claim AI can resolve 70 to 73% of routine e-commerce support calls without humans, threatening IBEX's tier-1 work. IBEX is responding by partnering with agentic AI vendor Sierra (announced May 5, 2026) and shifting toward regulated HealthTech, which grew 53.7% YoY to $34.1 million in Q3 FY2026.
Who is IBEX's biggest competitor?
Teleperformance (410,000+ employees, over $10 billion revenue) and Concentrix (450,000 employees, proprietary iX GenAI suite with 2,000+ bots deployed by FY2024) are the dominant BPO incumbents IBEX competes against as a much smaller challenger.
Who owns IBEX?
IBEX trades on Nasdaq (IBEX). Parent TRG held about 64% at its August 7, 2020 IPO; TRG affiliate TRGIL's stake was reported at approximately 13% as of March 31, 2026, though a separate source cites 28.8%, a discrepancy not yet resolved.
Is IBEX growing or shrinking?
By revenue, growing: FY2025 revenue was about $558.3 million (up ~9.8% YoY) and Q3 FY2026 revenue hit $164.4 million (up 17% YoY). By independent headcount data (Revelio Labs), the company appears to be shrinking, down about 14% from 2023 levels as of December 2025.
What is IBEX's AI strategy?
IBEX launched its own Wave iX GenAI platform on January 30, 2024, then announced a strategic partnership with agentic AI vendor Sierra on May 5, 2026, deploying it live with client Philippine Airlines and calling it 'accretive to BPO margins' and part of a 'BPO 3.0' era.
Timeline
  • 2026-05-12HealthTech vertical reported up 53.7% YoY to $34.1M, 20.8% of Q3 FY2026 revenue
  • 2026-05-06FY2026 guidance raised to $638-642M revenue, $82-84M adjusted EBITDA
  • 2026-05-05IBEX announces strategic partnership with Sierra for agentic AI CX deployments
  • 2026-03-31Q3 FY2026 revenue $164.4M, up 17% YoY; adjusted net income $13.6M
  • 2026-02-06IBEX opens new India operations to support HealthTech growth
  • 2025-12-31Revelio Labs estimates IBEX headcount at ~24,000-25,000, down ~7% YoY
  • 2024-01-30IBEX launches Wave iX AI-powered CX platform
  • 2020-08-07IBEX IPOs on Nasdaq; parent TRGI retains ~64% controlling stake
  • 2013-06IBEX Global Solutions plc lists on London AIM (predecessor to Nasdaq listing)
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
SierraTranscosmos Inc.Tanla Platforms
More in BPO and customer operations firms →
Sources